Skip to main content

03-04-2018 | JAK inhibitors | Review | Article

The rationale for Janus kinase inhibitors for the treatment of spondyloarthritis

​​​​​​​Veale DJ et al. Rheumatology (Oxford) 2018; Advance online publication. doi: 10.1093/rheumatology/key070

Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.

Related topics